Detalhe da pesquisa
1.
Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization.
J Virol
; 97(5): e0160422, 2023 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37098956
2.
Cholesterol reduction by immunization with a PCSK9 mimic.
Cell Rep
; 43(6): 114285, 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38819987
3.
Long trimer-immunization interval and appropriate adjuvant reduce immune responses to the soluble HIV-1-envelope trimer base.
iScience
; 27(2): 108877, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38318357
4.
Volatile profiling distinguishes Streptococcus pyogenes from other respiratory streptococcal species.
mSphere
; 8(5): e0019423, 2023 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37791788
5.
HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide.
Cell Rep
; 42(7): 112755, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37436899
6.
Soluble prefusion-closed HIV-envelope trimers with glycan-covered bases.
iScience
; 26(8): 107403, 2023 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37554450
7.
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial.
EClinicalMedicine
; 48: 101477, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35783486